Company: RAYA
Filing Date: 2025-09-29
Form Type: 424B5
Source: 0001185185-25-001296
Chunk: 94

Company: Erayak Power Solution Group Inc.
Filing Date: 2025-09-29
Form: 424B5
Chunk 94
---
RC and obtain such approval or complete such filing, as applicable” on page 17.

As of the date of this prospectus, according to
our PRC counsel, Gaopeng & Partners, although we are required to complete the filing procedure in connection with our offerings under
the Trial Measures, no relevant PRC laws or regulations in effect require that we obtain permission from any PRC authorities to issue
securities to foreign investors, and we have not received any inquiry, notice, warning, sanction, or any regulatory objection to this
offering from the CSRC, the CAC, or any other PRC authorities that have jurisdiction over our operations.

The Standing Committee of the National People’s
Congress, or the SCNPC, or other PRC regulatory authorities may in the future promulgate laws, regulations or implementing rules that
requires our company or any of our subsidiaries to obtain regulatory approval from Chinese authorities before listing in the U.S. In other
words, although the Company has not received any denial to list on the U.S. exchange, our operations could be adversely affected, directly
or indirectly; our ability to offer, or continue to offer, securities to investors would be potentially hindered and the value of our
securities might significantly decline or be worthless, by existing or future laws and regulations relating to its business or industry
or by intervene or interruption by PRC governmental authorities, if we or our subsidiaries (i) do not receive or maintain such permissions
or approvals, (ii) inadvertently conclude that such permissions or approvals are not required, (iii) applicable laws, regulations, or
interpretations change and we are required to obtain such permissions or approvals in the future, or (iv) any intervention or interruption
by PRC governmental with little advance notice. See “Risk Factors — Risks Related to Doing Business in China”
beginning on page 16 this prospectus for a discussion of these legal and operational risks and information that should be considered before
making a decision to purchase our Class A ordinary shares.

In addition, since 2021, the Chinese government
has strengthened its anti-monopoly supervision, mainly in three aspects: (1) establishing the National Anti-Monopoly Bureau; (2) revising
and promulgating anti-monopoly laws and regulations, including: the Anti-Monopoly Law (draft Amendment published on October 23, 2021 for
public opinions), the anti-monopoly guidelines for various industries, and the detailed Rules for the Implementation of the Fair